Skip to main content
. Author manuscript; available in PMC: 2018 May 27.
Published in final edited form as: Cell Rep. 2018 Jan 30;22(5):1250–1262. doi: 10.1016/j.celrep.2018.01.013

Figure 4. Traf6 Is Required for Maintaining HSC Quiescence.

Figure 4

(A) TUNEL positive VavCre+ or Traf6−/−VavCre+ Lin- and Lin+ BM cells (n = 4 per group).

(B) Representative cell-cycle analysis of VavCre+ or Traf6−/−VavCre+ CD150+LSK cells.

(C) Proportion of VavCre+ or Traf6−/−VavCre+ CD150+LSK cells (left) or LSK cells (right) in G0, G1 and S/G2/M phase (n = 4 per group).

(D) Frequency of BrdU+ staining in VavCre+ or Traf6−/−VavCre+ CD150+LSK cells (left) or LSK cells (n = 4 per group). *p < 0.05. Data are represented as mean ± SEM.